Shadi Tabibian: Normal Tests, Abnormal Bleeding
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn:
“Bleeding Disorders of Unknown Cause (BDUC) represent one of the most challenging areas in contemporary haemostasis.
Although patients experience clinically significant bleeding manifestation, including heavy menstrual bleeding, mucocutaneous bleeding, easy bruising, and procedure-related haemorrhage, standard haemostatic investigations frequently fail to identify an underlying defect.
As a result, many individuals, particularly women, face prolonged diagnostic delay, repeated specialist consultations, fragmented care pathways, and substantial psychosocial burden.
Emerging evidence suggests that BDUC is not a benign condition.
Patients report impaired quality of life, iron deficiency, reduced physical functioning, anxiety, and significant impacts on education, employment, and social participation. Importantly, the absence of a laboratory diagnosis does not equate to the absence of disease.
This infographic summarizes the multidimensional burden of BDUC in women, highlighting the interconnected relationship between bleeding symptoms, diagnostic uncertainty, healthcare challenges, physical consequences, and psychological impact.
Greater awareness, standardized diagnostic pathways, comprehensive phenotyping, and continued research into currently unexplained bleeding phenotypes are essential to improve outcomes for this underserved patient population.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI